EGFR exon 20 insertions and how to manage patients in the UK

In the first roundtable in a series of Lung Cancer Sessions organized by VJOncology and the British Thoracic Oncology Group (BTOG), leading UK thoracic experts Sanjay Popat, Alastair Greystoke, Anna Minchom and Riyaz Shah will discuss the identification of EGFR exon 20 insertions and how to manage patients in the UK, based on the recent decisions made by NICE on the use of amivantamab and mobocertinib.